Cancer Drugs Fund (CDF) https://www.epmmagazine.com/topics/cancer-drugs-fund-%28cdf%29/index.rss en-gb © 2020 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Mon, 29 Jan 2018 14:31:25 -0000 Thousands of patients benefitting from new CDF, says NHS England NHS England has revealed that thousands of patients have benefited from the new CDF and as a result of discounts it has secured on eight treatments, savings of around £140 million should be generated over the course of the next five years https://www.epmmagazine.com/news/thousands-of-patients-benefitting-from-new-cdf-says-nhs-engl/ https://www.epmmagazine.com/news/thousands-of-patients-benefitting-from-new-cdf-says-nhs-engl/ Mon, 29 Jan 2018 14:31:25 -0000 medicines Lung cancer drug now available on NHS thanks to new deal Opdivo, also known as nivolumab, will now be available to NHS patients suffering from lung cancer as the drug’s manufacturer, Bristol-Myers Squibb, offers the National Institute for Health and Care Excellence (NICE) a new cancer drugs fund (CDF) deal https://www.epmmagazine.com/news/lung-cancer-drug-now-available-on-nhs-thanks-to-new-deal/ https://www.epmmagazine.com/news/lung-cancer-drug-now-available-on-nhs-thanks-to-new-deal/ Wed, 20 Sep 2017 10:24:55 -0000 Lungs Felicity Thomas NHS Cancer Drugs Fund was not good value An analysis by King’s College London has found that the NHS Cancer Drugs Fund (CDF) was not good value for patients and society, and may have resulted in patients suffering from toxic side effects of the drugs. https://www.epmmagazine.com/news/nhs-cancer-drugs-fund-was-not-good-value/ https://www.epmmagazine.com/news/nhs-cancer-drugs-fund-was-not-good-value/ Fri, 28 Apr 2017 12:31:23 -0000 Money waste Breast cancer drug rejected for use within NHS A drug used to treat breast cancer has been rejected for use on the NHS due to its high cost. https://www.epmmagazine.com/news/breast-cancer-drug-rejected-for-use-within-nhs/ https://www.epmmagazine.com/news/breast-cancer-drug-rejected-for-use-within-nhs/ Mon, 16 Jan 2017 11:10:00 -0000 Breast Cancer 'Encouraging' lung cancer drug approved on NHS A drug that can lead to the reduction in lung cancer tumours has been made available on the NHS. https://www.epmmagazine.com/news/l/ https://www.epmmagazine.com/news/l/ Wed, 05 Oct 2016 14:50:00 -0000 Drugs Bottle New Cancer Drugs Fund opens for business Following a closed-door period, the UK's Cancer Drugs Fund is once again accepting new treatments. https://www.epmmagazine.com/news/new-cancer-drugs-fund-opens-for-business/ https://www.epmmagazine.com/news/new-cancer-drugs-fund-opens-for-business/ Mon, 01 Aug 2016 08:46:00 -0000 cancerdrugsfund.jpg Cancer Drugs Fund cuts don't save money, survey finds In light of NHS England's plan to remove 25 uses of cancer medicines from the Cancer Drugs Fund (CDF) on 12 March, a new survey has revealed considerable dissatisfaction amongst oncologists with some of the proposed changes. https://www.epmmagazine.com/news/cancer-drugs-fund-cuts-dont-save-money-survey-finds/ https://www.epmmagazine.com/news/cancer-drugs-fund-cuts-dont-save-money-survey-finds/ Tue, 10 Mar 2015 16:08:00 -0000 pills_dreamstime_xs_9970832.jpg Dave Gray NHS "fundamentally flawed" says Sanofi amid cancer drugs cuts Sanofi has spoken out about recent cuts to the UK's Cancer Drugs Fund, which will see at least two of its drugs delisted from March 12th. https://www.epmmagazine.com/news/sanofi-cancer-drugs-fund-nhs-zaltrap-jevtana/ https://www.epmmagazine.com/news/sanofi-cancer-drugs-fund-nhs-zaltrap-jevtana/ Tue, 13 Jan 2015 10:11:00 -0000 pills.jpg Thousands to benefit from additional £160 million for cancer drugs Thousands more cancer patients in England will be offered vital treatments in a £160 million boost to the Cancer Drugs Fund. https://www.epmmagazine.com/huber-now-has-a-portuguese-website/ https://www.epmmagazine.com/huber-now-has-a-portuguese-website/ Thu, 04 Sep 2014 12:39:00 -0000 money2.jpg Kadcyla’s rejection confirms that NICE must change the way it considers cancer treatment Jamie Mallinson, GlobalData’s analyst covering oncology and hematology, describes the NICE rejection as "no big surprise". https://www.epmmagazine.com/kadcyla%E2%80%99s-rejection-confirms-that-nice-must-change-the-way-i/ https://www.epmmagazine.com/kadcyla%E2%80%99s-rejection-confirms-that-nice-must-change-the-way-i/ Wed, 13 Aug 2014 09:24:23 -0000 rejected.jpg